News Releases & Statements
News Releases & Statements
Study in Nature Medicine Shows Superior Outcomes for Patients in LLS's Paradigm-Shifting Beat AML Clinical Trial
Posted On: October 22, 2020Rye Brook, NY (Monday, October 26, 2020) - Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal.
Read More
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt “Patient-First” Policy Agenda
Posted On: October 12, 2020October 13, 2020 – A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort today by releasing their top priorities for the next Administration. The report elevates the collective voices of patients and urges elected officials to ensure all people living in the United States, including those with pre-existing conditions, have access to adequate and affordable health coverage.
Read More
LLS and Burlington Stores Celebrate 19 Years of Partnership in the Fight Against Blood Cancer
Posted On: September 23, 2020 Read More
The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
Posted On: September 8, 2020Rye Brook, NY (Wednesday, Sept. 9, 2020) - With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population.
Read More
PRA Health Sciences Joins The Leukemia & Lymphoma Society on Global Trial for Children with Acute Leukemia
Posted On: September 2, 2020September 3, 2020, Rye Brook, N.Y. and Raleigh, N.C. - The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia.
Read More
Blood Cancer Patients Need Support Now More Than Ever
Posted On: August 27, 2020(Rye Brook, NY, Sept. 1, 2020) — Having blood cancer is tough. Having blood cancer now is even tougher. Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to fight this deadly disease — a disease that is diagnosed every three minutes in the U.S. and has no current means of prevention. Read More
LLS’s Team In Training Resilience Challenge Adds Meaning to Miles
Posted On: August 25, 2020An Innovative Virtual Challenge to Move, Fundraise, and Commemorate Blood Cancer Awareness Month
Read More
Media Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.